Diabetes Flashcards
Diagnostic glucose and HbA1c levels:
- fasting glucose >= 7mmol/L
- random glucose >=11.1mmol/L
- HbA1c >= 6.5% (48 mmol/mol)
Impaired fasting glucose:
> =6.1 and <7.0mmol/L
Impaired glucose tolerance:
<7.0mmol/L and 2 hour value >=7.8mmol/L and <11.1mmol/L
Metformin ADR
- GI upset
- lactic acidosis
- not if GFR <30ml/min
DPP-4 inhibitors
- gliptins (e.g. vildagliptin, sitagliptin)
- increased incretin levels and reduced glucagon
- oral
- good for obesity (no weight gain)
- risk of pancreatitis
SGLT-2 inhibitors
- gliflozins
- oral
- ADR: UTI, weight loss
GLP-1 agonists
- tides
- subcut
- exanatide subcut injection 60 mins before morning and evening meals
- liraglutide od
- can be combined with metformin and sulfonylurea if BMI >=35
- ADR: weight loss, pancreatitis, nausea and vomiting
Sulfonylureas
- gliclazide, glimepiride
- oral
- ADR: hypoglycaemia, weight gain, hyponatraemia
Thiozolidinediones
- oral
- ADR: weight gain, fluid retention
- pioglitazone
What can result in a lower than expected HbA1c?
- sickle cell anaemia
- hereditary spherocytosis
- GP6D deficiency
What is the algorithm for T1DM meds?
see notes
What can result in a higher than expected HbA1c?
- B12/folic acid deficiency
- iron deficiency anaemia
- splenectomy
What are the different HbA1c targets? (and how often checked)
- lifestyle (+metformin): 48mmol/mol
- lifestyle + drug that can cause hypoglycaemia: 53mmol/mol
- already on one drug but has risen to 58mmol/mol: 53mmol/mol
- checked every 3-6 months until stable and then every 6 months
What determines statin therapy in diabetes?
- QRISK >10% in 10 years: 20mg atorvastatin
- secondary prevention: 80mg atorvastatin
What are the HbA1c targets for T1DM?
- 48mmol/mol
- checked every 3-6 months
Describe glucose self-monitoring in T1DM:
- 4 times per day
- before each meal and before bed
- more frequent during pregnancy, exercise, increased hypo episodes, illness, breast feeding
What is diabetic foot disease secondary to? Complications? Most common bacteria?
- neuropathy: loss of sensation, Charcot’s arthropathy, dry skin
- peripheral arterial disease: intermittent claudication, reduced arterial foot pulses, reduced ABPI
- complications: gangrene, osteomyelitis, cellulitis, calluses, ulceration, Charcot’s arthropathy
- pseudomonas aeruginosa
DKA symptoms:
- abdominal pain
- polyuria, polydipsia, dehydration
- Kussmaul respiration
- acetone smelling breath
Management of DKA:
- fluid replacement priority
- start with isotonic saline
- insulin infusion IV 0.1/U/kg/hr
- when glucose <15mmol/L, 5% dextrose
- correct hypokalaemia
- continue long acting insulin, stop short acting
Complications of DKA:
- gastric stasis
- thromboembolism
- arrhythmias
- cerebral oedema
- ARDS
- AKI
Diabetic neuropathy treatment:
- 1st line: amytriptylline, duloxetine, pregabalin, gabapentin
- pain: tramadol
- topical capsaicin
- pain clinic
- gastroparesis: erythromycin, metoclopramide, domperidone
Presentation of HOHS
- don’t necessarily look dehydrated because of hypertonicity
- lethargy, nausea and vomiting, fatigue
- neurological: headaches, papilloedema, weakness
- hyperviscous blood - MI, thromboses
- hypotension, tachycardia
Diagnosis of HOHS
- hypovolaemic
- hyperglycaemic
- increased serum osmolarity
Treatment of HOHS
- IV 0.9% NaCl solution - gradual glucose and osmolarity decline (vigorous initial replacement)
- no insulin to begin with - cardiovascular collapse
- only insulin if significant ketonaemia
- replace potassium if required
What drug decreases hypoglycaemic awareness?
beta blockers
Side effects insulin?
- lipodystrophy (rotate injection sites to avoid)
- hypoglycaemia
Presentation and types of MODY
- development of T2DM <25yo
- autosomal dominant
- MODY 3: most common, HNF-1 alpha defect, increased risk HCC
- MODY 2: glucokinase gene defect
- MODY5: HNF-1 beta defect, increased liver and renal cysts
- sensitive to sulfonylureas
- insulin not usually required
What is prediabetes?
impaired glucose tolerance and fasting glucose
Diabetic nephropathy
- screen annually using urinary albumin:creatinine
- early morning specimen
- ACR >2.5 : microalbuminuria
- manage: dietary protein restriction, BP aim <130/80mmHg, ACEi or ARB, statins